Tumor Ablation Market to Experience Explosive Growth as Healthcare Goes Digital

Tumor ablation is a minimally invasive medical procedure used to destroy abnormal tissues or tumors, such as cancerous or non-cancerous growths, without the need for surgery. It is typically performed using various energy sources, including radiofrequency, microwave, laser, or ultrasound.

During a tumor ablation procedure, a small needle or probe is inserted into the tumor under guidance of imaging techniques, such as ultrasound or CT scan. The energy source is then applied to the probe, which generates heat that destroys the cancerous cells or abnormal tissues. The heat causes coagulation of the tissues and eventual necrosis, leading to the destruction of the tumor.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 - https://www.alliedmarketresearch.com/request-sample/17626#UTM_Source=OpenPR-Mahendra

𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 -

The tumor ablation market size was valued at $1.3 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 13.6% from 2022 to 2031.

𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝐊𝐢𝐝𝐧𝐞𝐲 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Tumor ablation is a minimally invasive procedure that uses various techniques to destroy tumors without surgery. In the context of kidney cancer, tumor ablation can be used as an alternative treatment for small renal masses (SRMs) that are less than 4 cm in size. The scope of the tumor ablation market in kidney cancer application is promising due to the increasing incidence of kidney cancer, advancements in ablation technologies, and a growing preference for minimally invasive procedures.

According to the American Cancer Society, kidney cancer is among the top ten most common cancers in both men and women, with an estimated 76,080 new cases and 13,780 deaths in the United States in 2022. The increasing incidence of kidney cancer has led to a demand for alternative treatments that can be used for early-stage disease. Tumor ablation is a viable option for these patients as it has been shown to be effective in treating SRMs, which are often found incidentally during imaging studies.
Technological advancements in ablation devices have also contributed to the growth of the market.

Newer devices such as microwave ablation, irreversible electroporation, and cryoablation have been developed and offer improved precision, safety, and efficacy over traditional radiofrequency ablation. These advancements have expanded the options available for patients and providers, making the procedure more accessible.

Furthermore, the preference for minimally invasive procedures has been increasing among patients due to the reduced risk of complications, faster recovery time, and improved quality of life. Tumor ablation is a minimally invasive procedure that can be performed on an outpatient basis, with minimal downtime and reduced side effects.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (262 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/tumor-ablation-market/purchase-options#UTM_Source=OpenPR-Mahedra

On the basis of application, the liver cancer segment was the highest revenue contributor in 2021, owing to an increase in liver cancer cases and lifestyle changes. However, the kidney cancer segment is expected to exhibit the fastest growth during the forecast period, owing to an increase in the number of kidney cancer cases, reduced physical activities, and excessive smoking and drinking.

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐭𝐮𝐦𝐨𝐫 𝐚𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞
• Abbott Laboratories,
• AngioDynamics Inc.,
• Bioventus (Misonix Inc.),
• Boston Scientific Corporation,
• ConMed Corporation,
• Elekta Inc.,
• Galil Medical Inc.,
• HealthTronics Inc.,
• Johnson & Johnson,
• Medtronic Plc.

𝐃𝐨 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐛𝐮𝐲𝐢𝐧𝐠 - https://www.alliedmarketresearch.com/purchase-enquiry/17626#UTM_Source=OpenPR-Mahendra

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.alliedmarketresearch.com/press-release/tumor-ablation-market.html

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-
𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.alliedmarketresearch.com/surgical-glue-market-A31580

𝐌𝐞𝐧𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 -
https://www.alliedmarketresearch.com/recombinant-vaccines-market-A17605

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐥𝐨𝐭𝐡𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 - https://www.alliedmarketresearch.com/medical-clothing-market-A17602

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

Alied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.